Company Haemonetics Corporation

Equities

HAE

US4050241003

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Haemonetics Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
87.66 ^USD	+1.67%		+5.03%	+2.51%

Apr. 04	Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge	MT
Apr. 04	Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	CI

Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.

Number of employees: 3,034

USD in Million	2022	Weight	2023	Weight	Delta
Plasma 42.8 %	352	35.4 %	500	42.8 %	+42.21%
Hospital 32.4 %	322	32.4 %	378	32.4 %	+17.61%
Blood Center 24.8 %	295	29.7 %	289	24.8 %	-1.76%
Service 1.8 %	21	2.1 %	21	1.8 %	+2.95%
Reconciling Items -1.8 %	4	0.4 %	-21	-1.8 %	-582.15%

USD in Million	2022	Weight	2023	Weight	Delta
United States 72.1 %	639	64.4 %	843	72.1 %	+31.84%
Europe 13.4 %	164	16.5 %	157	13.4 %	-4.18%
Asia 8.9 %	111	11.2 %	104	8.9 %	-6.02%
Japan 5.2 %	76	7.6 %	61	5.2 %	-18.88%
Other 0.3 %	4	0.4 %	4	0.3 %	-8.45%

Managers	Title	Age	Since
Christopher Simon CEO	Chief Executive Officer	60	16-05-15
James D'Arecca DFI	Director of Finance/CFO	53	22-04-10
Jan Hartmann CTO	Chief Tech/Sci/R&D Officer	-	06-07-31
Anila Lingamneni CTO	Chief Tech/Sci/R&D Officer	57	20-03-31
Olga Guyette IRC	Investor Relations Contact	-	16-01-31
Rajeev Varma PRN	Corporate Officer/Principal	-	18-07-31
Maryanne Farris AUD	Comptroller/Controller/Auditor	-	22-09-30
Josep Llorens PRN	Corporate Officer/Principal	62	18-07-31
David James Wilson PRN	Corporate Officer/Principal	-	17-09-17
Roy Galvin PRN	Corporate Officer/Principal	55	22-09-30

Members of the board	Title	Age	Since
Robert Abernathy BRD	Director/Board Member	69	17-10-17
Charles Dockendorff BRD	Director/Board Member	69	14-07-22
Ellen Zane CHM	Chairman	72	18-01-24
Michael Coyle BRD	Director/Board Member	62	20-04-15
Mark Kroll BRD	Director/Board Member	71	05-12-31
Claire Pomeroy BRD	Director/Board Member	69	19-04-23
Diane Bryant BRD	Director/Board Member	61	23-08-03
Christopher Simon CEO	Chief Executive Officer	60	16-05-15
Lloyd Johnson BRD	Director/Board Member	69	21-08-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,786,117	50,398,174 ( 99.24 %)	0	99.24 %

Name	Equities	%	Valuation
Capital Research & Management Co. (Global Investors) 12.85 %	6,523,568	12.85 %	557 M $
BlackRock Advisors LLC 11.33 %	5,752,864	11.33 %	491 M $
Vanguard Fiduciary Trust Co. 10.65 %	5,406,309	10.65 %	461 M $
LB Hercules Holdings LLC 6.953 %	3,531,181	6.953 %	301 M $
Wellington Management Co. LLP 6.435 %	3,268,083	6.435 %	279 M $
STATE STREET CORPORATION 3.524 %	1,789,636	3.524 %	153 M $
Fiduciary Trust Company International 3.335 %	1,693,880	3.335 %	145 M $
Fidelity Management & Research Co. LLC 3.109 %	1,578,735	3.109 %	135 M $
T. Rowe Price Investment Management, Inc. 2.151 %	1,092,299	2.151 %	93 M $
Geode Capital Management LLC 2.137 %	1,085,076	2.137 %	93 M $

Haemonetics Corp.

125 Summer Street

02110, Boston

+781 848 7100

http://www.haemonetics.com

Name	Category and Sector
Haemonetics SA Haemonetics SA Packaged SoftwareTechnology Services Haemonetics SA designs, manufactures, markets and services blood processing systems. The company is headquartered in Signy, Switzerland.	Packaged Software
Haemonetics Manufacturing, Inc. Haemonetics Manufacturing, Inc. Medical SpecialtiesHealth Technology Part of Haemonetics Corp., Haemonetics Manufacturing, Inc. is a private company that manufactures blood disposables sets and related medical devices. The company is based in Covina, CA.	Medical Specialties
Haemonetics International Finance SARL

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

86.22 USD

Average target price

104.9 USD

Spread / Average Target

+21.62%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
HAEMONETICS CORPORATION	+2.51%	4.38B
ABBOTT LABORATORIES	-2.92%	185B
MEDTRONIC PLC	-3.80%	107B
BECTON, DICKINSON AND COMPANY	-5.48%	67.55B
DEXCOM, INC.	+11.22%	54.6B
CENCORA, INC.	+16.74%	47.42B
HOYA CORPORATION	+3.86%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+4.56%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.64%	26.42B
TERUMO CORPORATION	+12.40%	25.66B

Other Medical Equipment, Supplies & Distribution